☰
×
News
Top 20
Insights
Insights+
ThoughtSpot
Interviews
Viewpoints
Exclusive
Spotlight
Events
Magazine
Bespoke
Newswire
x
Search
Search here
Search here
Subscribe Now
Phase 1b
BMS Expands its Collaboration with Compugen to Evaluate the Combination of COM701 + Opdivo
February 23, 2021
Xenon Pharmaceutical Reports Positive Results of XEN1101 P-1b TMS (transcranial magnetic stimulation) study
August 29, 2018
Biogen and Eisai Reports Results of Long-Term Extension P-Ib study for aducanumab
August 28, 2018
Load more...
Back to Home
Modal title
×
Modal body text goes here.
